# MarketFlow Additional Predictive Evidence Execution Candidate for Refined Evidence Operator Review Package Status

## Branch And Scope

- Branch: `feature/additional-predictive-evidence-execution-candidate-refined-evidence-review-v1`.
- Base/source candidate commit: `19f82a5157b0c81f0407f0789735c1041e6f07be`.
- Review commit: recorded by this document's implementing commit after validation.
- Scope: offline, digest-bound operator review of the exact refined-evidence execution candidate. No execution approval, execution, acceptance, or runtime authority is created.

## Review Artifact

- Artifact: `ADDITIONAL_PREDICTIVE_EVIDENCE_EXECUTION_CANDIDATE_FOR_REFINED_EVIDENCE_REVIEW_PACKAGE`.
- Status: `ADDITIONAL_PREDICTIVE_EVIDENCE_EXECUTION_CANDIDATE_FOR_REFINED_EVIDENCE_REVIEW_PACKAGE_READY`.
- Schema: `additional_predictive_evidence_execution_candidate_for_refined_evidence_review_v1`.
- Review digest: `5cee77990a1f40689ee45ab2f65e2adda070e79970e12d52169f7e88236f6e04`.
- Checklist: `84 / 84` passed, `0` failed, `0` blockers.

## Reviewed Candidate

- Candidate artifact/status: `ADDITIONAL_PREDICTIVE_EVIDENCE_EXECUTION_CANDIDATE_FOR_REFINED_EVIDENCE` / `ADDITIONAL_PREDICTIVE_EVIDENCE_EXECUTION_CANDIDATE_FOR_REFINED_EVIDENCE_READY_FOR_OPERATOR_REVIEW`.
- Candidate digest: `dce3a92d05eaba5c2b9307c08799c27bbadb69e804c27c157c7290eec705c340`.
- Candidate checklist: `75 / 75` passed, `0` failed, `0` blockers.
- Candidate objective: `PREPARE_ADDITIONAL_PREDICTIVE_EVIDENCE_EXECUTION_USING_REVIEWED_REFINED_FEATURE_LABEL_EVIDENCE`.
- Candidate scope/mode/authority: `REFINED_EVIDENCE_EXECUTION_CANDIDATE_ONLY_NOT_APPROVAL_NOT_EXECUTION` / `PLANNED_NOT_EXECUTED` / `NOT_AUTHORIZED`.

## Bound Source Evidence

- Feature/label refinement results-review digest: `00604008d3c647f45896cd8b6707de519ed6eda4e32566b3c99910441ec6cc79`.
- Feature/label refinement execution digest: `377d6d232dcdf4b94f9f2d66414ff994edca2d3d9d95f4fb97d9dbfaf2359b36`.
- Feature/label refinement execution approval digest: `1b98237ae9156875ca703396b6e1fabf2acf31ab607789247f8af2391d8b5c20`.
- Original additional-predictive-evidence results-review digest: `167a0399e99f46e895c9cdf6c70a3e650e20f60cb78641180de04e56f88caee8`.
- Original additional-predictive-evidence execution digest: `61a90d0b863da3ddfc3ef8eb744a1ef64c476a975d83faa2be19d0f199776ed3`.
- Research-registry approval digest: `5f0ce29bd06f1a0d5f1ce3dd8e31b8c8e52d616673f119326377538228d3d958`.
- Canonical-dataset freeze digest: `02af746fa11fa292a84e000ff8ca19a0b4ab36937558f938e4ac04eef6be92fc`.
- Canonical records digest: `fbd7c1b17b42e5d4f82a9162b31b45fdfeef46f0e9ee7d29d74c926f0cf19044`.

## Registry-Approved Dataset Metadata

- Dataset/scope: `expanded_universe_canonical_dataset_v1` / `CANONICAL_DATASET_GENERATION_RESEARCH_ONLY`.
- Registry status/label: `APPROVED_FOR_RESEARCH_REGISTRY_ONLY` / `RESEARCH_ONLY_NON_ACTIONABLE`.
- Source profile/timeframe: `RTH_FULL_SESSION_1D` / `1d`.
- Date range: `2022-01-01` through `2025-12-31`.
- Universe/records: `12 / 11946`; data quality `PASS_WITH_PRESERVED_SOURCE_LIMITATION`.

## Target Universe And Record Counts

- Exact order: `MSFT`, `NVDA`, `AMZN`, `GOOGL`, `META`, `TSLA`, `JPM`, `XOM`, `JNJ`, `WMT`, `CAT`, `LMT`.
- META has exactly `913` records; every other ticker has exactly `1003`.
- META's reduced source count is preserved without repair, inference, normalization, backfill, or fabrication.

## Refined Evidence Source Profile

- Source root/count/status: `.marketflow/feature_label_refinement/expanded_universe_v1/` / `12` / `REVIEWED_AND_VERIFIED`.
- Source results-review readiness: `True`.
- The review binds the validated source candidate and does not inspect, change, or rerun ignored refinement outputs.

## Refined Evidence Facts

- Labels: 7 families, 84 coverage entries, 82,698 available and 924 unavailable values; digest `04cf6925b956a0813c1b14e5009dc1fc4225179006589cc09d4f39721c749ee8`.
- Features: 9 groups, 11 categories, 19 fields, 11,946 rows and 1,128 null/unavailable values; digest `35bf96942c57b851ee1fea7255002115fb871c9245cef849b1689411192b7f00`.
- Protocol: 6 groups with chronological splits, one-session embargo, no shuffle, and no lookahead.
- Walk-forward/OOS: 4 folds, 3,024 walk-forward rows, 2,988 OOS rows, observed accuracy range `0.119813 to 0.480924`.
- Model/leakage/data quality: 5 model groups, 7 comparisons, 3 unavailable family requests, leakage `PASS / 0`, data quality `PASS_WITH_PRESERVED_SOURCE_LIMITATION`.

## Reviewed Refined Evidence Inputs

- All ten candidate inputs were reviewed and preserved.
- Each remains `SOURCE_REVIEWED_NOT_REEXECUTED` and `RESEARCH_ONLY_NON_ACTIONABLE`.

## Reviewed Planned Execution Activities

- All eleven candidate activities were reviewed and preserved.
- Each remains `PLANNED_NOT_EXECUTED`, `NOT_AUTHORIZED_FOR_EXECUTION`, and `RESEARCH_ONLY_NON_ACTIONABLE`.

## Reviewed Planned Outputs

- All ten candidate outputs were reviewed and preserved.
- Each remains `PLANNED_NOT_GENERATED` and `RESEARCH_ONLY_NON_ACTIONABLE`.

## Per-Ticker Candidate Review Summary

- Twelve ordered entries preserve candidate digests and add deterministic review digests.
- Every entry is `READY_FOR_OPERATOR_ASSESSMENT`; execution authorization and execution remain `False`.
- META alone retains the reduced-record flag and explicit preservation note.

## Future Refined-Evidence Execution Chain

1. This candidate operator review package.
2. Additional Predictive Evidence Execution Approval Ceremony for Refined Evidence, if selected.
3. Additional Predictive Evidence Execution for Refined Evidence.
4. Additional Predictive Evidence Results Review for Refined Evidence.
5. Predictive Usefulness Reassessment and Acceptance Readiness reviews.
6. Predictive Usefulness Acceptance Candidate, only if readiness passes.
7. Separate profitability and runtime chains, if required and authorized.

## Future Gates And Risk Controls

- Execution approval, execution, and results review remain distinct future gates.
- Predictive usefulness, profitability, and runtime decisions remain separate and closed.
- The review does not mutate the frozen dataset, rerun refinement evidence, infer acceptance, switch runtime sources, stitch automatically, trade, or recommend.
- No provider payload or API key is accessed, stored, committed, or printed.

## Execution Boundary

- Candidate/review created: `True / True`.
- Refined-evidence execution approval created/approved/authorized/performed/results created: `False / False / False / False / False`.
- Provider request, acquisition, dataset regeneration, refinement reruns, metrics recomputation, and model-comparison rerun: all `False`.

## Predictive Usefulness, Profitability, And Runtime Boundaries

- Predictive usefulness: `not accepted`; readiness/recommendation/candidate: `False / False / False`.
- Profitability: `not accepted`; readiness/recommendation: `False / False`.
- Runtime migration approved/active: `False / False`.
- Runtime/strategy/paper/broker: `NOT_AUTHORIZED / NOT_AUTHORIZED / NOT_AUTHORIZED / NOT_AUTHORIZED`.
- Automatic stitching, strategy scoring, and trade recommendations: all `False`.

## Next Task Recommendation

- Follow-on `Additional Predictive Evidence Execution Approval for Refined Evidence v1` is implemented on its stacked feature branch.
- This candidate review remains the bound source evidence for that approval.
- Approval authorizes only future refined-evidence execution; execution and results remain not performed/not created.
- Predictive usefulness and profitability remain not accepted, and runtime remains not authorized.
- Next separate task: `Additional Predictive Evidence Execution for Refined Evidence v1`.
